nephropathy
Novartis shares new data about Fabhalta for IgAN treatment
April 16, 2024Research and Development Fabhalta, IgAN, Nephrology, Novartis, nephropathy
Novartis has announced new results from a pre-specified interim analysis of its phase 3 APPLAUSE-IgAN trial of Fabhalta (iptacopan), an …
Vertex to acquire Alpine Immune Sciences for $4.9bn
April 11, 2024Business Services Alpine Immune Sciences, Nephrology, Vertex pharmaceuticals, acquisition, nephropathy
Vertex Pharmaceuticals and Alpine Immune Sciences have announced that they have entered into a definitive agreement under which Vertex will …
Calliditas’ kidney disease drug granted priority review by FDA
April 28, 2021Research and Development Calliditas, FDA, nephropathy, pharma, pharma news
The FDA has granted priority review for the New Drug Applicaton (NDA) for Calliditas Therapeutics’ Nefecon, for the treatment of …
AZ and Mitsubishi partner on diabetic nephropathy
August 20, 2014Research and Development, Sales and Marketing AstraZeneca, BMS, Mitsubishi, cvmd, diabetes, nephropathy
AstraZeneca and Japanese firm Mitsubishi Tanabe Pharma Corporation (MTPC) have signed a new three-year research deal in the area of …
